YCM
PASG icon

Yiheng Capital Management’s Passage Bio PASG Stock Holding History

Yiheng Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$420K Hold
86,097
– – 0.14% 27
2026
Q1 		$676K Buy
86,097
+51,796
+151% +$536K 0.29% 21
2025
Q4 		$405K Buy
+34,301
New +$296K 0.08% 23

Other funds holding PASG

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Yiheng Capital Management's PASG Position: Q2 2026 in Review

Yiheng Capital Management held its Passage Bio (PASG) position steady in Q2 2026 at 86,097 shares worth $420K. The position accounts for 0.14% of the portfolio, ranked #27.

Yiheng Capital Management first reported a position in PASG in Q4 2025 and has held it in 3 quarters since. The position peaked at $676K in Q1 2026. 30 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • Yiheng Capital Management held 86,097 shares of Passage Bio worth $420K as of Q2 2026.
  • Yiheng Capital Management left its Passage Bio share count unchanged in Q2 2026.
  • Passage Bio made up 0.14% of Yiheng Capital Management's portfolio in Q2 2026, its #27 holding.
  • Yiheng Capital Management first reported a position in Passage Bio in Q4 2025 and has held it in 3 quarters since.
  • Yiheng Capital Management's Passage Bio position peaked at $676K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Yiheng Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.